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sychiatryPriority Communication BPAge-Dependent Pleiotropy Between General
Cognitive Function and Major Psychiatric
Disorders
W. David Hill, Gail Davies, The CHARGE Cognitive Working Group,
David C. Liewald, Andrew M. McIntosh, and Ian J. DearyABSTRACT
BACKGROUND: General cognitive function predicts psychiatric illness across the life course. This study examines
the role of pleiotropy in explaining the link between cognitive function and psychiatric disorder.
METHODS: We used two large genome-wide association study data sets on cognitive function—one from older
age, n 5 53,949, and one from childhood, n 5 12,441. We also used genome-wide association study data on
educational attainment, n 5 95,427, to examine the validity of its use as a proxy phenotype for cognitive function.
Using a new method, linkage disequilibrium regression, we derived genetic correlations, free from the confounding of
clinical state between psychiatric illness and cognitive function.
RESULTS: We found a genetic correlation of .711, (p 5 2.26e-12) across the life course for general cognitive
function. We also showed a positive genetic correlation between autism spectrum disorder and cognitive function
in childhood (rg 5 .360, p 5 .0009) and for educational attainment (rg 5 .322, p 5 1.37e-5) but not in older age.
In schizophrenia, we found a negative genetic correlation between older age cognitive function (rg 5 2.231,
p 5 3.81e-12) but not in childhood or for educational attainment. For Alzheimer’s disease, we found negative genetic
correlations with childhood cognitive function (rg 5 2.341, p 5 .001), educational attainment (rg 5 2.324, p 5 1.15e-5),
and with older age cognitive function (rg 5 2.324, p 5 1.78e-5).
CONCLUSIONS: The pleiotropy exhibited between cognitive function and psychiatric disorders changed across
the life course. These age-dependent associations might explain why negative selection has not removed variants
causally associated with autism spectrum disorder or schizophrenia.
Keywords: Aging, Autism, Cognitive function, Genetics, Pleiotropy, SchizophreniaISShttp://dx.doi.org/10.1016/j.biopsych.2015.08.033General cognitive function describes the positive correlations
that exist between seemingly disparate tests of cognitive
function (1). This overlap accounts for around 40% of the
variation in cognitive test scores (2). Individual differences in
cognitive function are predictive of both physical and mental
health (3). Ageing has been shown to have differential effects
on the facets of cognitive function, whereby tests that include
novel information and/or invoke on-the-spot abstract reason-
ing skills, often termed tests of general ﬂuid cognitive function,
show decline from early adulthood onward (4,5). Tests of
crystallized function that include measurements of learned
material, such as vocabulary, are more robust to the ageing
process (6).
Higher general cognitive function in childhood is predictive
of lower self-reported psychological distress decades later (7).
This association between cognitive function and psychological
well-being extends to severe psychiatric conditions, with a 1
standard deviation lower score in general cognitive function
being associated with a 60% increased risk for hospitalization
for schizophrenia, a 50% increase for mood disorders, and a& 2015 Society of Biological Psy
N: 0006-3223
SEE COMMENTA75% greater risk for alcohol-related disorders in two decades
of follow-up (8). Indeed, a higher risk of several psychiatric
conditions has been associated with a lower level of cognitive
function, including major depressive disorder (9,10), attention-
deﬁcit/hyperactivity disorder (ADHD) (11), and autism spec-
trum disorder (ASD). There is also evidence for lower premor-
bid cognitive function in individuals who later develop bipolar
disorder (12,13), although higher premorbid cognitive function
may also confer risk (14).
Using genome-wide association study data, it has been
shown that general cognitive function is a highly polygenic trait
inﬂuenced by many common genetic variants (single nucleo-
tide polymorphisms [SNPs]) that each exert only a very small
effect on phenotypic variation (15). The genome-wide complex
trait analysis method of estimating SNP-based heritability
ﬁnds that common genetic variants tag causal variants that
together account for around 30% of general cognitive ability
variation (15–19). However, even in a meta-analysis of over
53,000 subjects, the variance accounted for by genome-wide
signiﬁcant loci was only a small fraction of this ﬁgure (15).chiatry. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/). 1
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Biological
PsychiatryThe genetic architecture of psychiatric disorders is also
highly polygenic, whereby the combined effect of many
common variants accounts for much of the heritability, and
as with cognitive function, the number of genome-wide
signiﬁcant loci do not explain the heritability accounted for
by all SNPs (20). The present study tests the hypothesis that
the phenotypic link between general cognitive function and
psychiatric disease is, at least in part, caused by pleiotropic
genetic variants.
Pleiotropy between traits can be inferred by applying the
polygenic prediction method to genome-wide association
study (GWAS) data sets (21). This method, often termed
polygenic risk scoring, uses markers selected from the
summary GWAS data in one sample to construct a weighted
genetic risk score for each individual in an independent
sample. An association between this composite score and
the trait of interest in the second sample is evidence of an
overlap between the polygenic architecture of each trait. This
method has been used to indicate that there are shared
genetic inﬂuences between, for example, higher risk of schiz-
ophrenia and lower cognitive function in older age and more
age-related cognitive decline (22,23) and between a greater
risk of ASD and higher cognitive function (24). However, the
polygenic prediction method suffers from a number of limi-
tations, including requiring access to genotype data, as well as
producing biased results in cases where the discovery and
replication samples overlap (25,26). By placing these addi-
tional constraints on the type of samples that can be used, the
total number of available participants, along with statistical
power, falls. In addition, there is a further loss of power as
informative markers may be lost due to pruning for linkage
disequilibrium (LD) (27).
Another method to quantify a genetic correlation is
restricted maximum likelihood analysis (28), where genotype
data are from the same group of individuals assessed on
multiple traits (29) or across multiple time points (30). This
method allows the full number of genome-wide markers to be
included in the analysis, meaning that, by contrast with the use
of polygenic risk scores, data are not lost through pruning.
However, this method suffers from the limitation that the same
individuals are required to have been assessed on multiple
traits. While this, at best, presents logistical difﬁculties in the
recruitment of a sample, in the case of psychiatric disorders,
the symptoms displayed by diagnosed individuals may inter-
fere with the cognitive test process resulting in an inﬂation of
the genetic correlation.
Here, to avoid the limitations associated with bivariate
restricted maximum likelihood and polygenic prediction, we
used a new method, LD regression (25,31), to derive a genetic
correlation using GWAS summary data. LD regression exploits
the ﬁnding that SNPs in regions of high LD provide a measure
of a greater proportion of the genome than SNPs in regions of
low LD. This means that, assuming a polygenic architecture,
SNPs in regions of high LD are more likely to capture variance
associated with a causal variant, leading to an increase in the
association test statistics from a GWAS proportional to the
level of LD in the region (32). As consequence of this, LD can
be used to predict GWAS test statistics. This logic extends to
the bivariate design where, at each loci, the product of the test
statistics from two GWAS replaces the association statistics2 Biological Psychiatry ]]], 2015; ]:]]]–]]] www.sobp.org/journalfrom a single GWAS. In the presence of a nonzero genetic
correlation between the traits measured by the two GWAS, the
level of LD can be used to predict the product of association
statistics at each loci (25,31).
We used LD regression, ﬁrst used by Bulik-Sullivan et al.
(25,31) to derive 300 genetic correlations between 25 traits.
Here, we focused on a smaller number of traits to provide
detailed analyses of pleiotropy between cognitive abilities and
psychiatric disorders and tests of whether these associations
change over time. In addition, we assessed the validity of the
use of educational attainment as a proxy phenotype for
cognitive function in genetic correlations with psychiatric
disorders. In the current study, we derived genetic correlations
between general cognitive function in the 53,949 individuals of
the Cohorts for Heart and Aging Research in Genomic
Epidemiology (CHARGE) consortium (age range 45–102) (15)
and the seven major psychiatric disorders. The disorders
examined were schizophrenia (33), bipolar disorder (34), major
depressive disorder (MDD) (35), ASD (20), attention-deﬁcit/
hyperactive disorder (20), anorexia nervosa (36), and Alz-
heimer’s disease (37). In addition, we used the summary data
from the GWAS meta-analysis of the Childhood Intelligence
Consortium (CHIC), which examined cognitive function in
childhood (n 5 12,441, age range 6–18) (17). We also used
summary data from a GWAS meta-analysis of educational
attainment (38), deﬁned as whether or not a college level of
education was achieved. Only one educational attainment
variable was used from this article by Rietveld et al. (38), as
they have been previously shown to genetically correlate at
rg 5 1.0 (25). The assessment of cognitive function in both
older age and childhood allows for a genetic correlation for
cognitive function to be derived across these two time points;
it also allows for a more mechanistic interpretation of any
cognitive function-psychiatric disorder genetic correlation that
is found, as variants responsible for the development of
cognitive function (childhood general cognitive function) and
variants that exert a protective effect against the ageing
process (older age general ﬂuid cognitive function) may exert
differential risk/protective effects against psychiatric disease.
We also included educational attainment to examine its use as
a proxy phenotype for general cognitive function.
METHODS AND MATERIALS
Samples
Summary data from GWAS meta-analyses of schizophrenia,
bipolar disorder, MDD, ADHD, ASD, anorexia nervosa, Alz-
heimer’s disease, older age general ﬂuid cognitive function,
childhood general cognitive function, and educational attain-
ment were used to derive genetic correlations. Table 1 pro-
vides details pertaining to the reference and the source of the
data for each of the phenotypes examined here.
Statistical Analysis
We implemented the same data processing pipeline as
implemented by Bulik-Sulivan et al. (25). First, a heritability Z
score of .4 and a mean χ2 statistic of .1.02 were used as
cutoffs to ensure that the GWAS data sets used contained
a sufﬁciently clear polygenic signal contributing toward
Table 1. The Samples Used with References
Phenotype
Sample
Size Reference Data
Older Age General Fluid
Cognitive Function
53,949 Davies et al., Molecular Psychiatry (2015) (15) N/A
Childhood General
Cognitive Function
12,441 Benyamin et al., Molecular Psychiatry (2013) (17) http://ssgac.org/documents/
CHIC_Summary_Benyamin2014.txt.gz
Educational Attainment 95,427 Rietveld et al., Science (2013) (38) http://ssgac.org/documents/
SSGAC_Rietveld2013.zip
Schizophrenia 70,100 Schizophrenia Working Group of the Psychiatric Genomics Consortium,
Nature (2014) (33)
http://www.med.unc.edu/pgc/ﬁles/
resultﬁles/pgc.scz.2012-04.zip
Alzheimer’s Disease 54,162 Lambert et al., Nature Genetics (2013) (37) http://www.pasteur-lille.fr/en/recherche/
u744/igap/igap_download.php
Bipolar Disorder 16,731 Psychiatric GWAS Consortium Bipolar Disorder Working Group, Nature
Genetics (2011) (34)
http://www.med.unc.edu/pgc/ﬁles/
resultﬁles/pgc.bip.2012-04.zip
MDD 18,759 Major Depressive Disorder Working Group of the Psychiatric GWAS
Consortium et al., Molecular Psychiatry (2013) (35)
http://www.med.unc.edu/pgc/ﬁles/
resultﬁles/pgc.mdd.2012-04.zip
ADHD 5422 Neale et al., Journal of American Academy of Child and Adolescent
Psychiatry (2010) (20)
http://www.med.unc.edu/pgc/ﬁles/
resultﬁles/pgc.adhd.2012-10.zip
ASD 10,263 Cross-Disorder Group of the Psychiatric Genomics Consortium, Lancet
(2013) (20)
http://www.med.unc.edu/pgc/ﬁles/
resultﬁles/pgc.cross.aut.zip
Anorexia Nervosa 17,767 Boraska et al., Molecular Psychiatry (2014) (36) http://www.med.unc.edu/pgc/ﬁles/
resultﬁles/gcan_meta-out.gz
The ﬁnal column, Data, contains links to the data sets used. The data set pertaining to older age cognitive function is not publically available.
Educational attainment indicates if a college or university degree was obtained. A sample size of 26,474 was used to derive the heritability of
older age general ﬂuid cognitive function in the CHARGE cohort as the quality control procedures used included an SNP if it was present in at least
half of the cohort.
ADHD, attention-deﬁcit/hyperactivity disorder; ASD, autism spectrum disorder; CHARGE, Cohorts for Heart and Aging Research in Genomic
Epidemiology; MDD, major depressive disorder; SNP, single nucleotide polymorphism.
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Psychiatryheritability. As the ADHD data set failed both of these quality
control procedures, it was removed from further analyses
(Table 2). Minor allele frequency (MAF) was ﬁltered to include
SNPs where MAF . .01. To ensure high imputation quality,
SNPs were ﬁltered to HapMap3 (https://www.sanger.ac.uk/
resources/downloads/human/hapmap3.html) SNPs with 1000
Genomes European MAF . .05 (http://www.genomicsengland.
co.uk/the-100000-genomes-project/). Indels and structural var-
iants were removed along with strand-ambiguous SNPs. Addi-
tionally, SNPs whose alleles did not match those in the 1000
Genomes were also removed. Finally, as outliers can increase
the standard error in a regression, genome-wide signiﬁcant
SNPs were removed, as were SNPs with very large effect sizes
(χ2 . 80). As the GWAS used here were of European ancestry,
the precomputed LD scores and weights were taken from the
Broad Institute (Cambridge, Massachusetts; http://www.broad
institute.org/∽bulik/eur_ldscores/). As it was not possible to
quantify the degree to which these samples overlapped, the
intercept of the regression model describing the genetic corre-
lation between the pairs of traits was left unconstrained. Differ-
ences between the genetic correlations produced by LD
regression were explored by deriving a Z score for the difference
between the two. Additionally, in the case of the Alzheimer’s
disease phenotype, a region encompassing 500 kilobase around
each side of the APOE locus was removed to ensure any
genetic correlations derived were not being driven solely by the
large effects found within this region.RESULTS
Univariate heritability analysis was performed on each of
the consortia’s phenotypes using LD regression (25). Theseresults are reported in Table 2. It should be noted that due to
the implementation of genomic control factors to control for
population stratiﬁcation, these heritability estimates will be
biased downward.
There was a signiﬁcant genetic correlation between general
ﬂuid cognitive function in older age and general cognitive
function in childhood, rg 5 .711, SE 5 .101, p 5 2.256e-12,
indicating substantial pleiotropy across the human life course.
Educational attainment showed a high and signiﬁcant
genetic correlation with childhood general cognitive function,
rg 5 .719, SE 5 .089, p 5 8.137e-16, demonstrating a high
level of pleiotropy between these two traits. The genetic
correlation between older age cognitive function and educa-
tional attainment was not computed because permission was
not granted by the CHARGE consortium to perform these
analyses. We next examined these ages separately to discover
if the polygenic variation at each age overlapped with that of
the six psychiatric disorders.
Table 3 shows the results of our testing for pleiotropy
between cognitive function in older age and in younger age
with major psychiatric disorders. These genetic correlations
were derived using LD regression (25,31) along with the
publically available data sets speciﬁed in Table 1. The poly-
genic component to childhood general function and educa-
tional attainment overlapped substantially and positively with
ASD, rg 5 .360 (SE 5 .108, p 5 .0009) and rg 5 .322 (SE 5
.074, p 5 1.37e-5), indicating that both childhood cognitive
function and educational attainment demonstrate pleiotropy
with ASD. This is consistent with earlier reports where poly-
genic scores indicated that a greater risk for ASD predicted
phenotypic variance for higher cognitive function (24). This
ﬁnding did not extend to the sample of older age generalBiological Psychiatry ]]], 2015; ]:]]]–]]] www.sobp.org/journal 3
Table 2. Results of the Quality Control Procedures Implemented to Test the Suitability of Each Data Set for Use with LD
Regression
Reference Phenotype Target Phenotype
Observed
Heritability
Observed
Heritability SE
Heritability
Z Score Mean χ2
Childhood General Cognitive Function Older age general ﬂuid function .304 .031 9.806 1.170
Educational attainment .719 .089 8.079 1.244
Schizophrenia .526 .025 21.040 1.861
Bipolar disorder .467 .045 10.378 1.190
MDD .157 .032 4.906 1.079
ADHD .188 .102 1.843 1.018
ASD .419 .059 7.102 1.073
Anorexia nervosa .315 .032 9.844 1.085
Alzheimer’s disease .070 .012 5.785 1.107
Older Age General Fluid Cognitive Function Childhood general cognitive function .274 .047 5.830 1.076
Schizophrenia .529 .023 23.000 1.800
Bipolar disorder .456 .043 10.604 1.186
MDD .152 .031 4.903 1.077
ADHD .245 .101 2.426 1.017
ASD .459 .060 7.650 1.066
Anorexia nervosa .503 .028 17.964 1.058
Alzheimer’s disease .062 .011 5.636 1.103
Educational Attainment Childhood general cognitive function .272 .047 5.787 1.076
Schizophrenia .524 .027 19.407 1.815
Bipolar disorder .462 .045 10.267 1.187
MDD .156 .031 5.032 1.077
ADHD .173 .103 1.680 1.019
ASD .443 .060 7.383 1.069
Anorexia nervosa .422 .031 13.613 1.064
Alzheimer’s disease .065 .012 5.417 1.104
The cutoffs used here were a heritability Z score of .4 and a mean χ2 statistic of .1.02. These ﬁgures were derived using SNPs common to both
the reference and the target phenotypes and so may ﬂuctuate between comparisons. The metrics of observed heritability, observed heritability SE,
heritability Z score, and mean χ2 columns pertain to the target phenotype. The ADHD cohort showed a lack of power to detect a consistent
polygenic signal for use with LD regression when compared with both reference phenotypes. Educational attainment indicates if a college or
university degree was obtained.
ADHD, attention-deﬁcit/hyperactivity disorder; ASD, autism spectrum disorder; LD, linkage disequilibrium; MDD, major depressive disorder; SE,
standard error; SNP, single nucleotide polymorphism.
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Psychiatrycognitive function (rg 5 .058, SE 5 .071, p 5 .413), despite its
having greater power than the childhood cognitive function
data set. This indicates that the positive genetic overlapTable 3. The Genetic Correlations Between Childhood Gene
Function, Educational Attainment, and Major Psychiatric Disord
Childhood General Cognitive Function Old
Trait rg SE p Value rg
Schizophrenia 2.044 .057 .443 2.2
Bipolar Disorder .136 .089 .125 2.1
MDD .033 .134 .805 2.1
ASD .360 .108 .0009a .0
Anorexia Nervosa .060 .102 .560 .1
Alzheimer’s Disease 2.341 .106 .001a 2.3
Educational attainment indicates if a college or university degree was o
ASD, autism spectrum disorder; MDD, major depressive disorder; rg, g
aResults passed Bonferroni correction (.05/18 5 .003).
4 Biological Psychiatry ]]], 2015; ]:]]]–]]] www.sobp.org/journalbetween greater ASD risk and higher cognitive function is
driven by variants that exert their effects on the development
of cognitive function rather than its maintenance in older age.ral Cognitive Function, Old Age General Fluid Cognitive
ers
Age General Fluid Cognitive Function Educational Attainment
SE p Value rg SE p Value
31 .033 3.81e-12a .060 .036 .093
33 .056 .017 .264 .062 2.15e-5a
18 .094 .210 2.144 .082 8.06e-2
58 .071 .413 .322 .074 1.37e-5a
09 .044 .013 .171 .051 7.14e-4a
24 .075 1.78e-5a 2.324 .074 1.15e-5a
btained. p values displayed are uncorrected.
enetic correlation; SE, standard error.
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PsychiatryThe difference between the genetic correlations of childhood
cognitive ability and older age cognitive ability was statistically
signiﬁcant, Z 5 2.337, p 5 .019, showing that the genetic
correlation between childhood general cognitive function was
signiﬁcantly greater than the genetic correlation between ASD
and older age cognitive function. None of the genetic corre-
lations between childhood cognitive function and other psy-
chiatric disorders were signiﬁcant.
There was a signiﬁcant negative genetic correlation
between cognitive function in older age and schizophrenia
(rg 5 2.231, SE 5 .033, p 5 3.806e-12), i.e., greater genetic
risk of schizophrenia was associated with lower cognitive
function in that age period. The direction of effect and
presence in older age and not childhood (rg 5 2.044,
SE 5 .057, p 5 .443) or in educational attainment (rg 5 .060,
SE 5 .036, p 5 .093) is consistent with ﬁndings using
polygenic scoring methods (22,23). Again, the difference
between the genetic correlations of older age general ﬂuid
cognitive function and childhood general cognitive function
with schizophrenia were statistically signiﬁcant, Z = 2.839,
p = .005. These results indicate that it is the unique genetic
elements of older age general ﬂuid cognitive function that are
responsible for the pleiotropy with schizophrenia.
For educational attainment, signiﬁcant genetic correlations
were found with bipolar disorder (rg = .264, SE = .062,
p = 2.15e-5), MDD (rg = 2.144, SE = .082, p = 8.06e-2), and
anorexia nervosa (rg = .171, SE = .051, p = 7.14e-4). The
positive genetic correlations with bipolar disorder and anorexia
nervosa indicate that the genetic variants that contribute toward
these disorders also serve to increase educational attainment.DISCUSSION
We used the LD regression method, developed by Bulik-
Sullivan et al. (25,31), to test genetic correlations (based on
common genetic markers) between general cognitive function
in childhood and older age, educational attainment, and major
psychiatric disorders. We report several novel ﬁndings. We
found the ﬁrst signiﬁcant genetic correlation between cognitive
function in childhood and older age. We found a positive
genetic correlation between autism spectrum disorder and
cognitive function in childhood and in educational attainment
but not older age. We found a negative genetic correlation
between schizophrenia and cognitive function in older age but
not childhood or for educational attainment. We found genetic
correlations between Alzheimer’s disease and all three meas-
ures of cognitive function across the life course.
The LD regression method does not require the same
individuals to be measured in the same phenotype and so
the presence of the symptoms associated with these disor-
ders cannot confound the results of this study. In addition, the
overlapping control participants did not bias these results as
they would have done with polygenic scoring (27), meaning
that all genotyped participants could be included, keeping
statistical power relatively high.
The genetic correlation between childhood general cogni-
tive function and older age was rg 5 .711, SE 5 .101, p 5
2.256e-12, indicating that whereas a signiﬁcant proportion
of the genetic variance was shared between the mean ages
of these cohorts (CHIC 5 10.96 years, age range 6–18;CHARGE 5 66.40 years, age range 45–102), they were not
identical and possessed unique genetic factors. The magni-
tude of this correlation was larger, though similar, to that
previously reported using longitudinal samples (30). Pheno-
typic heterogeneity between the CHIC and the CHARGE
consortia may have led to an attenuation of this correlation,
as the measure of general cognitive function extracted from
different batteries of cognitive tests has been shown to
correlate between .79 and 1 (39,40).
Childhood cognitive function showed a large genetic cor-
relation with educational attainment (rg = .719), indicating a
substantial level of pleiotropy between these two phenotypes.
This ﬁnding provides support for the idea that educational
attainment can be used as a proxy phenotype (41,42) for
childhood cognitive function, as the same genetic variants are
associated with individual differences in both of these
variables.
The statistically signiﬁcant positive overlap between the
polygenic components of ASD and childhood general cogni-
tive function builds on the ﬁndings of Clarke et al. (24), who
reported a positive association between the polygenic score
derived from a GWAS on ASD that could predict a signiﬁcant
proportion of the variance for general cognitive function
in a sample of 52-year-olds (beta 5 .068, p 5 6e-7) and in a
sample of 17-year-olds (beta 5 .073, p 5 .029) but not in a
sample of 70-year-olds (beta 5 .02, p 5 .55) or 79-year-olds
(beta 5 2.03, p 5 .48), indicating that as the age of the cohort
increased, the degree to which the polygenic architecture of
ASD overlapped with cognitive function was attenuated. While
the modest sample sizes used by Clarke et al. (24) precluded a
formal test of this hypothesis, here we incorporate much larger
sample sizes in two nonoverlapping age groups to show that,
during childhood, the polygenic contribution of common
variants to ASD overlaps positively and substantially with
common SNPs tagging the variants responsible for childhood
general cognitive function, but by older age, pleiotropic
common variants between cognitive function and ASD are
not found. This indicates that the lack of association between
polygenic scores derived using ASD data sets and childhood
cognitive ability have been underpowered (24).
The direction of this effect, an increase in the common
variants underlying general cognitive function, meaning an
increase in common risk alleles to autism, appears to contrast
with earlier results using the twin method where negative
genetic correlations were found in childhood (43,44). However,
in these studies, both ASD status and general cognitive
function were assessed in the same individuals. Should the
symptoms of ASD impact on test performance, any alleles
truly associated with ASD would also show negative associ-
ations with cognitive test scores. The present study disen-
tangles these confounds by measuring cognitive functioning in
a separate sample from those with ASD.
A negative genetic correlation between ASD and cognitive
function has also been suggested, as de novo copy number
variation at 16p11.2, associated with ASD (45), has also been
shown to be associated with cognitive function in non-ASD
control subjects (46). However, the discrepancy between
these previous studies and the current study can be attributed
to the frequency of the genetic variants being studied. While
rare or de novo variants associated with ASD may haveBiological Psychiatry ]]], 2015; ]:]]]–]]] www.sobp.org/journal 5
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Psychiatrydeleterious consequences for cognitive function, the common
polygenic architecture of ASD is associated with an increase in
cognitive functioning.
The genetic correlation between older age general cognitive
function and schizophrenia is consistent with previous reports
featuring the polygenic scoring method (22,23). Another study
using polygenic scores assembled using 9394 cases and
12,462 control subjects (47) showed those with greater
polygenic scores derived from a schizophrenia data set
showed a lower level of cognitive function in older age, as
well as a greater level of cognitive decline from age 11 to age
70 (22). However, in the same study, no such effect was found
using individuals at age 11. The ﬁnding that the polygenic
component associated with schizophrenia is associated with
only older age general cognitive function indicates that it is the
variants that are protective of age-related cognitive decline,
rather than the variants responsible for the development of
cognitive function or the development of cognitive function,
that drive the genetic correlation between cognitive function
and schizophrenia.
The positive genetic correlation between educational attain-
ment and ASD, as well as the lack of genetic correlation
between educational attainment and schizophrenia, indicates
that whereas educational attainment can serve as a proxy
phenotype for childhood cognitive ability, it does not capture
the same genetic variants as older age cognitive function. The
data sets on educational attainment assembled by Rietvald
et al. (38) were composed of individuals who were aged 30
years and below, and as the polygenic burden for schizo-
phrenia acts later in life to increase the rate of cognitive
decline (22), it may be that these participants were too young
to experience the results of any polygenic effects that might
manifest later in the life course.
Educational attainment also demonstrated a positive
genetic correlation between bipolar disorder and with anorexia
nervosa, as ﬁrst reported by Bulik-Sullivan et al. (25). The
results for bipolar disorder follow the same trend as childhood
cognitive ability but were not signiﬁcant in the smaller child-
hood sample. Previous work examining educational attain-
ment and the risk of bipolar disorder has shown that risk
increases at both ends of the educational attainment spec-
trum, with children attaining very high grades showing the
greatest degree of risk (48). The results of the current study
provide molecular genetic evidence that high cognitive func-
tion before age 30 is inﬂuenced by some of the genetic
variants that inﬂuence the onset of bipolar disorder. The lack
of association with childhood ability in the current study may
indicate a lack of power in the sample. For anorexia nervosa,
the positive genetic correlation with educational attainment
concurs with some reports indicating that those with anorexia
nervosa score higher on tests of cognitive function (49). The
failure to ﬁnd a genetic correlation in either the older or
younger samples on general cognitive function may indicate
a lack of power or age-dependent pleiotropy. The genetic
correlation with older age cognitive function was .11 (nominally
signiﬁcant but did not survive correction for multiple testing)
and was not very different from that of .17 for educational
attainment. The lack of genetic correlation between schizo-
phrenia and educational attainment indicates that whereas
educational attainment could be used as a proxy phenotype6 Biological Psychiatry ]]], 2015; ]:]]]–]]] www.sobp.org/journalfor cognitive function in childhood, it does not capture the
relevant genetic variants involved in cognitive function in
older age.
The notion of an age-dependent association between
common variants and cognitive function has been previously
demonstrated with rs10119 located in the APOE/TOMM40
region (15). It was shown that between the ages of 55 and 80,
there is a signiﬁcant negative correlation between the effect
size of the A allele of the rs10119 locus and age, and at age
55, the effect for this allele was 0. The average age of the older
age cohort here was 66.4 years, meaning that they were an
age where age-dependent genetic effects on cognitive func-
tion are known to come into play. Here, we provide the ﬁrst
molecular genetic evidence that it is the combined signal from
these alleles that exhibit pleiotropy with schizophrenia.
Alzheimer’s disease demonstrated similar pleiotropy with
each of the three cognitive measures used here: childhood
cognitive function (rg 5 2.341), older age cognitive function
(rg 5 2.324), and educational attainment (rg 5 2.324). This
indicates that across the life course, variants inﬂuencing
Alzheimer’s disease contribute toward cognitive function. This
association was not driven by the APOE locus, as this region
was removed from the analysis. This ﬁnding provides molec-
ular genetic evidence for the system integrity hypothesis,
which states that high levels of cognitive function are, in part,
the product of a body that has complex systems that are
better integrated, which, in turn, makes it resistant to disease
(50). As this association begins in childhood and is of the same
magnitude in older age, it does not appear to be driven by
age-related decline but rather indicates that the genotypic
blueprint that is resistant to Alzheimer’s disease is also
associated with higher levels of the stable trait of general
cognitive function through much of the life course.
The age-dependent links with cognitive function found here
can help explain why such risk variants remain common in the
population. As cognitive function is associated with indicators
of ﬁtness including mortality (51) and health (3), this antago-
nistic pleiotropy between ASD and childhood general cogni-
tive function provides, perhaps, some of the explanation why
negative selection has not removed deleterious variants from
the population. In the case of schizophrenia, providing the
environmental antecedents of schizophrenia are absent, such
variants appear to be deleterious to cognitive function in later
life. This could indicate that such variants can survive in a
population as they are passed to the next generation before
the harmful effects are made apparent.
The results of this study provide evidence that there is a
substantial overlap between the genetic variants that affect
cognitive function across the life span. In addition, we show
that the unique genetic variants responsible for cognitive
variation in older age overlap with the polygenic component
of schizophrenia and in the case of childhood cognitive
function ASD. These ﬁndings add to the body of knowledge
detailing the pleiotropy between normal cognitive variation and
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